Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heartful Study: Landiolol in Pediatric Supraventricular Tachyarrhythmia With Low Cardiac Function
jRCT2080222859Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of landiolol in supraventricular tachycardia (SVT), Atrial fibrillation (AFib), atrial flutter (AFL) and 1 more, sponsored by Ono Pharmaceutical. Primary endpoint: Efficacy on supraventricular tachyarrhythmias. Started May 2015; status: completed.
02
Drugs
landiolol
03
Conditions
supraventricular tachycardia (SVT)Atrial fibrillation (AFib)atrial flutter (AFL)heart failure (HF)
Beyond the preview
Go deeper on jRCT2080222859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222859.